Abstract

Anatomic staging remains the most important prognostic factor in most malignancies, and it typically guides treatment selection. Clinical staging of prostate cancer with digital rectal examination poorly captures the true anatomic extent of disease, especially in the era of prostate-specific antigen–detected cancers. Hence, multiple investigators have explored the utility of MRI to more accurately stage prostate cancer and help guide treatment selection.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.